AbbVie Inc. EPS (Diluted) 2011-2026 | ABBV
Beta
What is eps (diluted)?
Diluted earnings per share (EPS) can be defined as net income divided by the total number of shares outstanding including all dilutive securities such as stock options, warrants, and convertible bonds.
What is AbbVie Inc.'s current eps (diluted)?
AbbVie Inc. (ABBV) annual eps (diluted) for 2025 was $2.36, a 1.26% decline from 2024. AbbVie Inc. eps (diluted) for the quarter ending March 31, 2026 was $0.39.
What was AbbVie Inc.'s eps (diluted) in 2024?
AbbVie Inc. annual eps (diluted) for 2024 was $2.39, a 12.13% decline from 2023.
What was AbbVie Inc.'s eps (diluted) in 2023?
AbbVie Inc. annual eps (diluted) for 2023 was $2.72, a 58.97% decline from 2022.
What is AbbVie Inc.'s 5-year eps (diluted) CAGR?
AbbVie Inc. eps (diluted) grew at a compound annual growth rate (CAGR) of 2.80% from FY2020 to FY2025, going from $2.72 to $2.36 over 5 years.
EPS (Diluted) History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-2.8%
FY2020
$2.72
→
FY2025
$2.36
111213141516171819202122232425
5 years selected
EPS (Diluted) History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $2.36 | -1.3% | 10-K |
| FY2024 | $2.39 | -12.1% | 10-K |
| FY2023 | $2.72 | -59.0% | 10-K |
| FY2022 | $6.63 | +2.8% | 10-K |
| FY2021 | $6.45 | +137.1% | 10-K |
| FY2020 | $2.72 | -48.5% | 10-K |
| FY2019 | $5.28 | +44.3% | 10-K |
| FY2018 | $3.66 | +10.9% | 10-K |
| FY2017 | $3.30 | -9.1% | 10-K |
| FY2016 | $3.63 | +16.0% | 10-K |
| FY2015 | $3.13 | +184.5% | 10-K |
| FY2014 | $1.10 | -57.0% | 10-K |
| FY2013 | $2.56 | -23.6% | 10-K |
| FY2012 | $3.35 | +53.7% | 10-K |
| FY2011 | $2.18 | - | 10-K |
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →